Signals and Noise in Drug Safety Analyses: The incretin therapy debate provides the rationale for revamping epidemiologic pharmacovigilance (Editorial)
William T. Cefalu, Julio Rosenstock, Robert R. Henry, and Matthew Riddle Diabetes Care July 2013 36:1804-1806; published ahead of print May 21, 2013 http://care.diabetesjournals.org/content/36/7/1804.extract.html
Leggi